Yahoo Web Search

Search results

1. • Newswise Expert | Anthony B. El-Khoueiry, Keck Medicine of USC

     Newswise· 4 days ago

     Dr. El-Khoueiry completed his medical degree, residency in internal medicine and fellowship in hematology and oncology at the Keck School of Medicine of the University of ...

2. • Slowing inflammation may boost immunotherapy’s e | Newswise

     Newswise· 5 days ago

     PHILADELPHIA – Adding an anti-inflammatory drug to anti-PD1 checkpoint inhibitor immunotherapy has shown great promise as a new strategy against advanced lung cancer, based on results from a ...

3. • 

     Why are Mustang Bio shares (MBIO) up almost 500%? | Invezz Why are Mustang Bio shares (MBIO) up...

     Invezz· 5 days ago

     The pharmaceutical company has gone vertical in the past 24 hours, climbing 476.9% to go from $0.13...

4. • Newswise Expert | Heinz-Josef Lenz, Keck Medicine of USC

     Newswise· 4 days ago

     Heinz-Josef Lenz, M.D., FACP, is the Associate Director for Clinical Research and Co-Leader of the Gastrointestinal Cancers Program at the USC Norris Comprehensive ...

5. • Live from EHA 2024 | Posters Featuring Results from Three Studies of Olverembatinib, Including...

     FOX 23 News Albany· 5 days ago

     Building on the data reported at the 2023 American Society of Hematology Annual Meeting, Ascentage Pharma has released the updated median 1-year follow-up data of olverembatinib ...

6. • ...ARTiDe: A novel regulatory T celltherapy for type 1 diabetes - Paris, Ile-de-France (FR) job with...

     Nature· 3 days ago

     Type 1 diabetes (T1D) is an incurable disease, often starting in childhood, caused by the autoimmune destruction of insulin-producing beta cells, yet the standard of care is insulin replacement ...

7. • 

     UC, UC Health ready to open $131M center at former Shriners site: PHOTOS - Cincinnati Business...

     The Business Journals· 2 days ago

     The Blood Cancer Healing Center, a collaboration between University of Cincinnati and UC Health, is...

8. • Newswise Expert | Alok Khorana, Case Western Reserve University

     Newswise· 7 days ago

     ...Clinic Lerner College of Medicine, Case Western Reserve University, the Sondra and Stephen Hardis Chair in Oncology Research, Vice-Chair for Clinical Services of the Taussig Cancer Institute (part of Case Comprehensive Cancer Center) and Director of the Gastrointestinal...

9. • Gene editing technology is revolutionizing disease treatment | The Excerpt

     USA TODAY via Yahoo News· 3 days ago

     I'm also co-chair of an antisemitic sub genome editing consortium that's really focused on advancing this towards in vivo genome editing. I see many different clinical trials ...

10. • Reviews Cross-Journal Editorial Team

      Nature· 3 days ago

      Reviews Cross-Journal Editorial Team